FDA Approved: ZENPEP — Supplemental Application (Aimmune Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Zenpep (pancrelipase) submitted by Aimmune Therapeutics, expanding or updating its labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatic Resection
• Pancreatitis

Drugs mentioned

• ZENPEP (pancrelipase)

Snippet

SUPPL AP for ZENPEP (PANCRELIPASE LIPASE, PANCRELIPASE PROTEASE, PANCRELIPASE AMYLASE)